|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: SOLECTRON CORP, 10-K, EX-23.1, 2000-11-13 |
Next: PROGENICS PHARMACEUTICALS INC, 10-Q, 2000-11-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> AUG-25-2000
<PERIOD-END> AUG-25-2000
<CASH> 1,475,564
<SECURITIES> 958,564
<RECEIVABLES> 2,154,958
<ALLOWANCES> 8,619
<INVENTORY> 3,787,287
<CURRENT-ASSETS> 8,628,208
<PP&E> 1,849,792
<DEPRECIATION> 769,402
<TOTAL-ASSETS> 10,375,632
<CURRENT-LIABILITIES> 3,216,803
<BONDS> 3,319,518
0
0
<COMMON> 604
<OTHER-SE> 3,801,549
<TOTAL-LIABILITY-AND-EQUITY> 10,375,632
<SALES> 14,137,444
<TOTAL-REVENUES> 14,137,444
<CGS> 12,862,216
<TOTAL-COSTS> 12,862,216
<OTHER-EXPENSES> 566,112
<LOSS-PROVISION> 5,066
<INTEREST-EXPENSE> 71,612
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> 500,728
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> (3,480)
<NET-INCOME> 497,248
<EPS-BASIC> 0.83
<EPS-DILUTED> 0.80
</TABLE>
|
|